20190319:100745 0001193125-19-035416 CORRESP 1 20190212 Stealth BioTherapeutics Corp 0001696396 2834 000000000 E9 1231 CORRESP 275 GROVE STREET SUITE 3-107 NEWTON MA 02446 617-600-6888 275 GROVE STREET SUITE 3-107 NEWTON MA 02446 CORRESP 1 filename1.htm CORRESP

Stealth BioTherapeutics Corp

c/o Intertrust Corporate Services (Cayman) Limited

190 Elgin Avenue

George Town, Grand Cayman

KY1-9005 Cayman Islands

February 12, 2019

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Stealth BioTherapeutics Corp

    

Registration Statement on Form F-1

    

File No. 333-229097

    

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-229097), as amended, so that it may become effective at 4:30 p.m. Eastern time on February 14, 2019, or as soon thereafter as practicable.

[The remainder of this page is intentionally left blank.]


Very truly yours,

 

Stealth BioTherapeutics Corp

By:   /s/ Irene P. McCarthy

Name:

Title:

 

Irene P. McCarthy

Chief Executive Officer

 

[Signature Page to Acceleration Request]